Mathematical model of 5-[(125)I]iodo-2'-deoxyuridine treatment: Continuous infusion regimens for hepatic metastases Journal Article

  


Authors: Sgouros, G.; O'Donoghue, J. A.; Larson, S. M.; MacApinlac, H.; Larson, J. J.; Kemeny, N.
Article Title: Mathematical model of 5-[(125)I]iodo-2'-deoxyuridine treatment: Continuous infusion regimens for hepatic metastases
Abstract: Purpose: Due to the cytotoxicity of DNA-bound iodine-125, 5- [125I]Iodo-2'-deoxyuridine ([125I]IUdR), an analog oF thymidine, has long been recognized as possessing therapeutic potential. In this work, the feasibility and potential effectiveness of hepatic artery infusion of [125I]IUdR is examined. Methods: A mathematical model has been developed that simulates tumor growth and response to [125I]IUdR treatment. The model is used to examine the efficacy and potential toxicity of prolonged infusion therapy. Treatment of kinetically homogeneous tumors with potential doubling times of either 4, 5, or 6 days is simulated. Assuming uniformly distributed activity, absorbed dose estimates to the red marrow, liver and whole-body are calculated to assess the potential toxicity of treatment. Results: Nine to 10 logs of tumor-cell kill over a 7- to 20-day period are predicted by the various simulations examined. The most slowly proliferating tumor was also the most difficult to eradicate. During the infusion time, tumor-cell loss consisted of two components: A plateau phase, beginning at the start of infusion and ending once the infusion time exceeded the potential doubling time of the tumor; and a rapid cell-reduction phase that was close to log-linear. Beyond the plateau phase, treatment efficacy was highly sensitive to tumor activity concentration. Conclusions: Model predictions suggest that [125I]IUdR will be highly dependent upon the potential doubling time of the tumor. Significant tumor cell kill will require infusion durations that exceed the longest potential doubling time in the tumor-cell population.
Keywords: human tissue; treatment planning; liver neoplasms; treatment indication; models, biological; antimetabolites, antineoplastic; continuous infusion; tumor cell culture; prediction; mathematical model; cancer inhibition; liver metastasis; iodine radioisotopes; feasibility studies; infusions, intra-arterial; cell count; cell killing; modeling; hepatic artery infusion; idoxuridine; humans; human; priority journal; article; 125iodine; iododeoxyuridine
Journal Title: International Journal of Radiation Oncology, Biology, Physics
Volume: 41
Issue: 5
ISSN: 0360-3016
Publisher: Elsevier Inc.  
Date Published: 1998-07-15
Start Page: 1177
End Page: 1183
Language: English
DOI: 10.1016/s0360-3016(98)00175-8
PUBMED: 9719130
PROVIDER: scopus
DOI/URL:

https://www.scopus.com/inward/record.uri?eid=2-s2.0-0032527685&doi=10.1016%2fS0360-3016%2898%2900175-8&partnerID=40&md5=8b4eb5bc83f61a8d794b690a461df5ff
Notes: Article -- Export Date: 12 December 2016 -- Source: Scopus
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. George Sgouros
    146 Sgouros
  2. Homer Macapinlac
    106 Macapinlac
  3. Joseph O'Donoghue
    151 O'Donoghue
  4. Steven M Larson
    958 Larson
  5. Nancy Kemeny
    543 Kemeny
Related MSK Work